XVZ-27823-90400
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Pfizer-BioNTech
- 2021-03-09
- 2021-03-10
- 2021-03-11
-
2021-03-31
Dose 2 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
-
2021-04-14
Survey response — day 14, dose 2MedDRA: Migraine, Office visit — Feeling: Poor · Get care from a doctor or other healthcare professionalFree text: Symptoms: Migraine · Healthcare visit (other): Visit to my OBGYN and chiropractorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-03-31 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-14 | Unsuccessful |
Free text
Release 7 — day 14, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release